James B. Harris

974 total citations
32 papers, 415 citations indexed

About

James B. Harris is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Oncology. According to data from OpenAlex, James B. Harris has authored 32 papers receiving a total of 415 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pulmonary and Respiratory Medicine, 7 papers in Physiology and 5 papers in Oncology. Recurrent topics in James B. Harris's work include Immunodeficiency and Autoimmune Disorders (5 papers), Asthma and respiratory diseases (5 papers) and Pancreatic and Hepatic Oncology Research (3 papers). James B. Harris is often cited by papers focused on Immunodeficiency and Autoimmune Disorders (5 papers), Asthma and respiratory diseases (5 papers) and Pancreatic and Hepatic Oncology Research (3 papers). James B. Harris collaborates with scholars based in United States, Germany and Hungary. James B. Harris's co-authors include Miles Weinberger, Edward G. Nassif, Gary D. Smith, Gary Milavetz, Ling‐Yi Chang, James D. Crapo, Richard C. Ahrens, Mark R. Stein, Isaac Melamed and William R. Lumry and has published in prestigious journals such as Cancer, Annals of Surgery and CHEST Journal.

In The Last Decade

James B. Harris

29 papers receiving 394 citations

Peers

Countries citing papers authored by James B. Harris

Since Specialization

Citations

This map shows the geographic impact of James B. Harris's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James B. Harris with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James B. Harris more than expected).

Fields of papers citing papers by James B. Harris

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James B. Harris. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James B. Harris. The network helps show where James B. Harris may publish in the future.

Co-authorship network of co-authors of James B. Harris

This figure shows the co-authorship network connecting the top 25 collaborators of James B. Harris. A scholar is included among the top collaborators of James B. Harris based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James B. Harris. James B. Harris is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A 20-Year Analysis of Risk Factors for Complicated Postoperative Course Following Laparoscopic Cholecystectomy 2025 ·The American Surgeon ·Ahmad Zeineddin, James B. Harris, (unknown), (unknown), Terrence M. Fullum, Edward E. Cornwell, Mallory Williams	0
2	Robotic cholecystectomy reduces the conversion rate in patients with obesity 2025 ·The Surgeon ·(unknown), (unknown), (unknown), (unknown), (unknown), James B. Harris	1
3	Evaluating the benefit of serology during potential Australian bat lyssavirus and rabies post-exposure prophylaxis 2023 ·Australian and New Zealand Journal of Public Health ·James B. Harris, (unknown), Jim Smith, (unknown), Megan K Young	0
4	BT595, a 10% Human Normal Immunoglobulin, for Replacement Therapy of Primary Immunodeficiency Disease: Results of a Subcohort Analysis in Children 2022 ·Journal of Clinical Immunology ·Gergely Kriván, Michael Borte, Pere Soler‐Palacín, Joseph A. Church, (unknown), James B. Harris, Phil Lieberman, Isaac Melamed, James N. Moy, Réka Simon, Silke Aigner, (unknown), Christiane Staiger	2
5	A national quality improvement study identifying and addressing cancer screening deficits due to the COVID‐19 pandemic 2022 ·Cancer ·(unknown), Heidi Nelson, Timothy W. Mullett, Scott H. Kurtzman, (unknown), James B. Harris, Katharine Yao, Brian C. Brajcich, Karl Y. Bilimoria, William G. Cance	21
6	Twenty-Five Years of Cancer Follow-Up; Is the Data Worth the Effort? 2021 ·Annals of Surgical Oncology ·Brian C. Brajcich, Bryan E. Palis, Ryan McCabe, Letícia Nogueira, Daniel J. Boffa, Sharon S. Lum, James B. Harris, (unknown), Timothy W. Mullett, Karl Y. Bilimoria, Heidi Nelson	2
7	Bone Marrow Findings of Immune-Mediated Pure Red Cell Aplasia Following Anti-Programmed Cell Death Receptor-1 Therapy: A Report of Two Cases and Review of Literature 2019 ·Journal of Hematology ·(unknown), James B. Harris, Imran Siddiqi, (unknown)	8
8	Immune Globulin Subcutaneous, Human – Klhw 20% for Primary Humoral Immunodeficiency: An Open-Label, Phase III Study 2019 ·Immunotherapy ·John W. Sleasman, William R. Lumry, Iftikhar Hussain, H. James Wedner, James B. Harris, (unknown), Elsa Mondou, Lin Jiang, Mark R. Stein	4
9	Efficacy, Safety, and Pharmacokinetics of a New 10 % Liquid Intravenous Immunoglobulin Containing High Titer Neutralizing Antibody to RSV and Other Respiratory Viruses in Subjects with Primary Immunodeficiency Disease 2016 ·Journal of Clinical Immunology ·Richard L. Wasserman, William R. Lumry, James B. Harris, Robyn J. Levy, Mark R. Stein, Lisa R. Forbes, Charlotte Cunningham‐Rundles, Isaac Melamed, Ai Kobayashi, Wei Du, Roger H. Kobayashi	23
10	Safety, Efficacy and Pharmacokinetics of a New 10% Liquid Intravenous Immunoglobulin (IVIG) in Patients with Primary Immunodeficiency 2012 ·Journal of Clinical Immunology ·Richard L. Wasserman, Joseph A. Church, Mark R. Stein, James N. Moy, Martha V. White, Steven Strausbaugh, Harry W. Schroeder, Mark Ballow, James B. Harris, Isaac Melamed, David Elkayam, William R. Lumry, Daniel Suez, Syed M. Rehman	46
11	Factor Analysis of the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) in a Large Sample of Patients Suspected of Dementia 2010 ·Applied Neuropsychology ·Andrew L. Schmitt, Ronald B. Livingston, (unknown), (unknown), (unknown), James B. Harris	25
12	166 A phase I dose-escalation study of anti-a5β1 integrin monoclonal antibody (M200) in patients with refractory solid tumors 2004 ·European Journal of Cancer Supplements ·(unknown), (unknown), A. W. Tolcher, Garry Schwartz, James B. Harris, Robert Stagg, Eric K. Rowinsky, Gregory E. Wilding	6
13	Does Cisapride Influence Cardiac Rhythm? Results of a United States Multicenter, Double-Blind, Placebo-Controlled Pediatric Study 2001 ·Journal of Pediatric Gastroenterology and Nutrition ·Joseph Levy, Christopher Hayes, Jeffrey A. Kern, James B. Harris, Alex F. C. Flores, Jeffrey S. Hyams, Ruth Murray, Vasundhara Tolia	17
14	Serum neopterin in chronic beryllium disease 1997 ·American Journal of Industrial Medicine ·James B. Harris, Becki Bucher Bartelson, (unknown), Ronald Balkissoon, Kathleen Kreiss, Lee S. Newman	12
15	Rat Lung Alveolar Type I Epithelial Cell Injury and Response to Hyperoxia 1991 ·American Journal of Respiratory Cell and Molecular Biology ·James B. Harris, Ling‐Yi Chang, James D. Crapo	38
16	Autologous Fat Injection for Vocal Cord Medialization in the Canine Larynx 1991 ·The Laryngoscope ·David P. Hill, Arlen D. Meyers, James B. Harris	10
17	Comparison of the intensity and duration of effects of inhaled bitolterol and albuterol on airway caliber and airway responsiveness to histamine 1990 ·Journal of Allergy and Clinical Immunology ·James B. Harris, Richard C. Ahrens, (unknown), (unknown), (unknown), (unknown)	5
18	Oral Bioavailability of Slow-Release Theophylline from Unencapsulated Beads in Preschool Children with Chronic Asthma 1988 ·Therapeutic Drug Monitoring ·Leigh M. Vaughan, Gary Milavetz, Miles Weinberger, Gary D. Smith, James B. Harris	3
19	Relationship between rate and extent of absorption of oral theophylline from Uniphyl brand of slow-release theophylline and resulting serum concentrations during multiple dosing 1987 ·Journal of Allergy and Clinical Immunology ·(unknown), (unknown), Miles Weinberger, James B. Harris, (unknown)	8
20	Acute Viral Laryngotracheitis Complicated by Herpes Simplex Virus Infection 1987 ·Otolaryngology ·James B. Harris, Rodney P. Lusk, Jeffrey S. Wagener, Richard D. Andersen	14

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact